Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitrite (AIR001) in Pulmonary Hypertension
NCT01431313Phase 2Completed
- Start
- Jun 2012
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of inhaled nitrite in pulmonary hypertension (PH). Primary endpoint: Change in Pulmonary Vascular Resistance. Started Jun 2012; status: completed.
02
Drugs
inhaled nitrite
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01431313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431313.